Related Experiment Videos
Insights
Protecting infants from serious diseases is possible through childhood immunizations. This article details the benefits and risks of vaccines recommended in the U.S. for children under one year old.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Childhood immunizations are crucial for preventing infectious diseases.
- Understanding vaccine risks and benefits is essential for informed healthcare decisions.
Purpose of the Study:
- To provide comprehensive information on vaccines for infants under one year of age in the U.S.
- To detail the risks and benefits of routine childhood vaccines.
- To present the recommended immunization schedule.
Main Methods:
- Review of scientific literature on vaccine efficacy and safety.
- Analysis of vaccine composition (live/killed organisms).
- Presentation of the American Academy of Pediatrics' immunization schedule.
Main Results:
- Vaccines stimulate local and systemic immunity.
- Information provided on diphtheria, pertussis, tetanus, poliomyelitis, Haemophilus influenzae, influenza, and hepatitis B vaccines.
- Risks and diseases prevented by each routine vaccine are outlined.
Conclusions:
- Routine childhood immunizations are a safe and effective method for disease prevention.
- Ongoing research aims to improve existing vaccines and develop new ones.
- Adherence to the recommended immunization schedule is vital for infant health.
Abstract:
Many childhood diseases can be prevented by proper immunization. The purpose of this article is to provide information about the risks and benefits associated with vaccines used in the United States for children under one year of age. Vaccines can be made from live or killed organisms and can stimulate both local and systemic immunity. The immunization schedule recommended by the American Academy of Pediatrics is presented. Information about the use of routine vaccines, their risks and the diseases they prevent, is presented. Vaccines included are diphtheria, pertussis, tetanus, poliomyelitis, Haemophilus influenzae, influenza viruses and hepatitis B. Research is ongoing to develop new vaccines and improve those currently in use.